Janux Q3'26 Revenue Estimate Is 8.03M USD
Janux Therapeutics is scheduled to report Q3'26 results on November 10; revenue is estimated at 8.03 million USD and EPS at (0.47) USD. The announcement time is not specified.
JANX (Janux Therapeutics, Inc.) is set to announce its Q3'26 results on November 10, time not specified. The earnings are expected to be disclosed at 7:00 AM ET (12:00 PM UTC).For Q3'26, revenue estimate is 8.03 million USD with EPS (earnings per share) anticipated at (0.47) USD. Learn more details…